Evaluation of 1H-pyrazol-1-yl benzenesulfonamide derivatives in alleviating inflammatory bowel disease via PI3K/Akt/mTOR signaling pathway in zebrafish models
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025
DOI: 10.1007/s00210-025-04807-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von S P Ramya Ranjan Nayak und 8 weiteren Autor:innen. Beteiligte Einrichtung: Toxicology and Pharmacology Laboratory, Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Katt…. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Inflammatory Bowel Diseases, Sulfonamides, Pyrazoles. Die Arbeit nennt 56 Literaturangaben.
Abstract (Originalsprache)
The incidence of inflammatory bowel disease (IBD) is increasing in developed nations, leading to a significant increase in healthcare expenses. It is characterized by chronic intestinal inflammation driven by excessive oxidative stress and dysregulated immune responses, leading to epithelial injury and impaired mucosal healing. Existing treatments have adverse effects, patient noncompliance issues, and high costs, emphasizing the need for new treatments. Pyrazole derivatives are promising antioxidant and anti-inflammatory bioactive compounds. This study uses zebrafish to test 1H-pyrazol-1-yl benzenesulfonamide derivatives for IBD treatment. Through network pharmacology and molecular docking, various 1H-pyrazol-1-yl benzenesulfonamide derivatives were screened, and T8 (4-(5-(4-chlorophenyl)-3-(2-(4-phenoxybenzylidene)hydrazine-1-carbonyl)-1H-pyrazol-1-yl)benzenesulfonamide) was chosen for in vitro and in vivo evaluation. T8 at 200 μM exhibited dose-dependent antioxidant (> 80%) and anti-inflammatory (> 85%) activities in vitro. In the zebrafish intestine, administering T8 at 150 μM led to a reduction in reactive oxygen species (ROS) (2.97-fold), lipid peroxidation, cellular apoptosis (2.30-fold), and macrophage accumulation. It restored superoxide dismutase (SOD) (19.49 U/mg) and catalase (CAT) (0.54 U/mg) levels while reducing malondialdehyde (MDA) (0.44 μmol), lactate dehydrogenase (LDH) (0.23 U/mg), and nitric oxide (NO) (3.61 μmol) levels. The expression levels of proinflammatory cytokines in zebrafish intestines were significantly reduced due to T8 suppressing the PI3K/Akt/mTOR signaling pathway. The gut histoarchitecture was restored after T8 treatment, as shown by histological analysis. By modulating the PI3K/Akt/mTOR signaling pathway, T8 reduced inflammation and oxidative stress in zebrafish, reducing IBD symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Toxicology and Pharmacology Laboratory, Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, 603203, Chengalpattu District, Tamil Nadu, India.
- Dr APJ Abdul Kalam Research Lab, Department of Pharmaceutical Chemistry, SRM College of Pharmacy, Faculty of Medicine and Health Sciences, SRM Institute of Science and Technology, Kattankulathur, 603203, Chengalpattu Di…
- Department of Pharmacology, SRM College of Pharmacy, Faculty of Medicine and Health Sciences, SRM Institute of Science and Technology, Kattankulathur, 603203, Chengalpattu District, Tamil Nadu, India.
- Department of Pharmacy, School of Medical and Allied Sciences, K.R. Mangalam University, Gurugram, India. ajayguru040996@gmail.com.
- Department of Biochemistry, College of Science, King Saud University, P.O. 2455, 11451, Riyadh, Saudi Arabia.
- Department of Botany and Microbiology, College of Science, King Saud University, P.O. 2455, 11451, Riyadh, Saudi Arabia.
Zitieren
APA
Nayak, S. P. R. R., Priya, D., Chitra, V., Guru, A., Elsadek, M. F., Elshikh, M. S., Arokiyaraj, S., Kathiravan, M. K., & Arockiaraj, J. (2025). Evaluation of 1H-pyrazol-1-yl benzenesulfonamide derivatives in alleviating inflammatory bowel disease via PI3K/Akt/mTOR signaling pathway in zebrafish models. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04807-3
Vancouver
Nayak SPRR, Priya D, Chitra V, Guru A, Elsadek MF, Elshikh MS, et al. Evaluation of 1H-pyrazol-1-yl benzenesulfonamide derivatives in alleviating inflammatory bowel disease via PI3K/Akt/mTOR signaling pathway in zebrafish models. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04807-3
BibTeX
@article{Nayak2025,
author = {Nayak, S P Ramya Ranjan and Priya, D and Chitra, V and Guru, Ajay and Elsadek, Mohamed Farouk and Elshikh, Mohamed S and Arokiyaraj, Selvaraj and Kathiravan, M K and Arockiaraj, Jesu},
title = {Evaluation of 1H-pyrazol-1-yl benzenesulfonamide derivatives in alleviating inflammatory bowel disease via PI3K/Akt/mTOR signaling pathway in zebrafish models},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
doi = {10.1007/s00210-025-04807-3}
}
EUVIMED